Prediction of KIT Mutation in Gastrointestinal Stromal Tumors by the Immunoprofile of the Tumor Cells

Journal of the Formosan Medical Association

Volumn 109, Issue 1, 2010, Pages 25-31

  Chou, Chu Chung ^a,b   Chou, Ming Jen ^b   Tzen, Chin Yuan ^c,d,e  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

gastrointestinal stromal tumors; immunohistochemistry; KIT; mutation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; PROTEIN S 100; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; COLON TUMOR; CONTROLLED STUDY; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE MUTATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PROTO ONCOGENE; RECTUM TUMOR; SMALL INTESTINE TUMOR; STOMACH TUMOR; TUMOR CELL;

ACTINS; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; FEMALE; FORECASTING; GASTROINTESTINAL STROMAL TUMORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-KIT; S100 PROTEINS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 76749148980     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(10)60018-6     Document Type: Article

References (18)

1. DeMatteo R.P., Lewis J.J., Leung D., et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 231 (2000) 51-58
2. Graadt van Roggen J.F., van Velthuysen M.L., and Hogendoorn P.C. The histopathological differential diagnosis of gastrointestinal stromal tumours. J Clin Pathol 54 (2001) 96-102
3. Joensuu H., Roberts P.J., Sarlomo-Rikala M., et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344 (2001) 1052-1056
4. van Oosterom A.T., Judson I., Verweij J., et al. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. Lancet 358 (2001) 1421-1423
5. Heinrich M.C., Corless C.L., Demetri G.D., et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21 (2003) 4342-4349
6. Debiec-Rychter M., Sciot R., Le Cesne A., et al. EORTC Soft Tissue and Bone Sarcoma Group; The Italian Sarcoma Group; Australasian Gastro-Intestinal Trials Group. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumors. Eur J Cancer 42 (2006) 1093-1103
7. He H.Y., Fang W.G., Zhong H.H., et al. Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST). Zhonghua Bing Li Xue Za Zhi 35 (2006) 262-266
8. Tzen C.Y., Wang M.N., and Mau B.L. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors. Eur J Surg Oncol 34 (2008) 563-568
9. Andersson J., Bumming P., Meis-Kindblom J.M., et al. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis. Gastroenterology 130 (2006) 1573-1581
10. Martín J., Poveda A., Llombart-Bosch A., et al. Spanish Group for Sarcoma Research. Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol 23 (2005) 6190-6198
11. Agaram N.P., Baren A., Arkun K., et al. Comparative ultra-structural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors. Ultrastruct Pathol 30 (2006) 443-452
12. Miettinen M., Makhlouf H., Sobin L.H., et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopatho-logic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol 30 (2006) 477-489
13. Miettinen M., Sobin L.H., and Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohisto-chemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 29 (2005) 52-68
14. Corless C.L., McGreevey L., Haley A., et al. KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 160 (2002) 1567-1572
15. Agaimy A., Wunsch P.H., Hofstaedter F., et al. Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations. Am J Surg Pathol 31 (2007) 113-120
16. ACCE Model Process for Evaluating Genetic Tests. Available at http://www.cdc.gov/genomics/gtesting/ACCE/index.htm [Date accessed: January 7, 2009]
17. Tzen C.Y., Huang Y.W., and Fu Y.S. Is atypical follicular adenoma of the thyroid a preinvasive malignancy?. Hum Pathol 34 (2003) 666-669
18. Tzen C.Y., and Mau B.L. Analysis of CD117-negative gastrointestinal stromal tumors. World J Gastroenterol 11 (2005) 1052-1055